Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Research & Development Expenses

The r&d expense for Zimmer Biomet Holdings, Inc. (ZBH) is $458.50 Million with a year-over-year change of +4.82%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.

ZBH R&D Expense Chart

ZBH R&D Expense
$458.50M+161.25% 20Y
Zoom

Current R&D Expense

$458.50M

$458.50 Million

Year-over-Year Change

+4.82%

vs. $437.40M prior year

Historical Data

28

Years of data available

Annual R&D Expense History

YearR&D ExpenseYoY Change% Change
2025$458.50M+$21.10M+4.82%
2024$437.40M$-21.30M-4.64%
2023$458.70M+$52.70M+12.98%
2022$406.00M$-29.80M-6.84%
2021$435.80M+$113.00M+35.01%
2020$322.80M$-126.50M-28.15%
2019$449.30M+$57.60M+14.71%
2018$391.70M+$21.80M+5.89%
2017$369.90M+$4.30M+1.18%
2016$365.60M+$96.80M+36.01%
2015$268.80M+$76.90M+40.07%
2014$191.90M$-12.30M-6.02%
2013$204.20M$-21.40M-9.49%
2012$225.60M$-12.80M-5.37%
2011$238.40M+$19.90M+9.11%
2010$218.50M+$12.80M+6.22%
2009$205.70M+$13.40M+6.97%
2008$192.30M$-17.30M-8.25%
2007$209.60M+$21.30M+11.31%
2006$188.30M+$12.80M+7.29%
2005$175.50M+$8.80M+5.28%
2004$166.70M+$60.90M+57.56%
2003$105.80M+$25.10M+31.10%
2002$80.70M+$9.10M+12.71%
2001$71.60M+$19.60M+37.69%
2000$52.00M+$7.00M+15.56%
1999$45.00M+$9.00M+25.00%
1998$36.00M
Data as of Saturday, June 20, 2026

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos